What is Osteocentric Technologies?
OsteoCentric Technologies, headquartered in Austin, Texas, is at the forefront of developing a novel medical device technology platform named Unifi. This innovative system is engineered to provide robust mechanical integration with bone, thereby empowering surgeons with immediate primary stability during procedures. The company's focus on enhancing surgical outcomes through advanced technology positions it as a key player in the medtech industry.
How much funding has Osteocentric Technologies raised?
Osteocentric Technologies has raised a total of $30M across 1 funding round:
Unspecified
$30M
Unspecified (2021): $30M with participation from Squadron Capital and OnPoint Advisors
Key Investors in Osteocentric Technologies
Squadron Capital
Squadron Capital is a private equity investment firm with a significant focus on the Asia Pacific region, known for constructing and managing portfolios of private equity funds and co-investments. Their expertise lies in deep due diligence and analysis of investment opportunities.
OnPoint Advisors
OnPoint Advisors is a nationwide consulting firm specializing in sales, marketing, operations, and strategy for small to medium-sized businesses, particularly in the retail, financial, and consumer sectors. They offer hands-on, personalized solutions to complex business issues.
What's next for Osteocentric Technologies?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Osteocentric Technologies. This capital infusion is likely to be directed towards scaling manufacturing operations, expanding clinical trials, and broadening market reach for the Unifi platform. The company's trajectory suggests a strong emphasis on commercialization and establishing a dominant market presence in orthopedic integration solutions.
See full Osteocentric Technologies company page
